INSR and neoplasm: Furthermore, KIAA1324 has been reported to counteract insulin signaling by interacting with insulin receptor (INSR) and insulin-like growth factor 1 receptor (IGF1R) and inhibit cell proliferation, supporting the tumor-suppressive role of KIAA1324 [18].